Literature DB >> 22261352

Open conformation tissue transglutaminase testing for celiac dietary assessment.

Kumar Pallav1, Daniel A Leffler, Michael Bennett, Sohaib Tariq, Hua Xu, Toufic Kabbani, Allan C Moss, Melinda Dennis, Ciaran P Kelly, Detlef Schuppan.   

Abstract

OBJECTIVES: Anti tissue-transglutaminase antibody is the mainstay of celiac disease serologic testing. Whilst it has high sensitivity in patients on an unrestricted diet, sensitivity is poor for evaluation of gluten free diet adherence. AIM: To assess the utility of a novel assay measuring Immunoglobulin-A antibodies to catalytically active open conformation tissue-transglutaminase in assessment of ongoing gluten exposure in celiac disease patients on an alleged gluten free diet.
METHODS: Through prospective assessment, 147 patients with celiac disease were divided into good and poor adherence. Open and closed (conventional) tissue-transglutaminase titres were measured using standard enzyme linked immunosorbent assay. 50 patients with inflammatory bowel disease served as disease controls.
RESULTS: Overall 128 patients had been on gluten free diet for more than six months and 19 were found to be poorly adherent on dietary review. Within this group 13 (68.4%) and 10 (52.6%) patients respectively were positive for the open conformation and conventional assay (p=0.51). Two and one control patients tested positive for closed and open assays respectively.
CONCLUSIONS: Compared to native assays open conformation tissue-transglutaminase may have higher sensitivity in the poor gluten free diet adherence group and higher specificity in the control population. Larger population studies are warranted to assess whether the open conformation tissue-transglutaminase assay may be superior to the conventional assay.
Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22261352      PMCID: PMC3384702          DOI: 10.1016/j.dld.2011.12.008

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  20 in total

1.  A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.

Authors:  Carlo Catassi; Elisabetta Fabiani; Giuseppe Iacono; Cinzia D'Agate; Ruggiero Francavilla; Federico Biagi; Umberto Volta; Salvatore Accomando; Antonio Picarelli; Italo De Vitis; Giovanna Pianelli; Rosaria Gesuita; Flavia Carle; Alessandra Mandolesi; Italo Bearzi; Alessio Fasano
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

2.  Factors that influence adherence to a gluten-free diet in adults with celiac disease.

Authors:  Daniel A Leffler; Jessica Edwards-George; Melinda Dennis; Detlef Schuppan; Francis Cook; Debra L Franko; Jessica Blom-Hoffman; Ciaran P Kelly
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 3.  Celiac disease.

Authors:  Peter H R Green; Christophe Cellier
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

4.  Low-dose gluten challenge in celiac sprue: malabsorptive and antibody responses.

Authors:  Gail G Pyle; Brian Paaso; Barbara E Anderson; Diane Allen; Thomas Marti; Chaitan Khosla; Gary M Gray
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

5.  Etiologies and predictors of diagnosis in nonresponsive celiac disease.

Authors:  Daniel A Leffler; Melinda Dennis; Brian Hyett; Eoin Kelly; Detlef Schuppan; Ciaran P Kelly
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-26       Impact factor: 11.382

6.  Calcium activation of tissue transglutaminase in radioligand binding and enzyme-linked autoantibody immunoassays in childhood celiac disease.

Authors:  Daniel Agardh; Bodil Roth; Ake Lernmark; Pål Stenberg
Journal:  Clin Chim Acta       Date:  2005-08       Impact factor: 3.786

7.  A simple validated gluten-free diet adherence survey for adults with celiac disease.

Authors:  Daniel A Leffler; Melinda Dennis; Jessica B Edwards George; Shailaja Jamma; Suma Magge; Earl F Cook; Detlef Schuppan; Ciaran P Kelly
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-11       Impact factor: 11.382

8.  A prospective comparative study of five measures of gluten-free diet adherence in adults with coeliac disease.

Authors:  D A Leffler; J B Edwards George; M Dennis; E F Cook; D Schuppan; C P Kelly
Journal:  Aliment Pharmacol Ther       Date:  2007-11-01       Impact factor: 8.171

Review 9.  Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.

Authors:  L Elli; C M Bergamini; M T Bardella; D Schuppan
Journal:  Dig Liver Dis       Date:  2009-02-04       Impact factor: 4.088

10.  Transglutaminase 2 undergoes a large conformational change upon activation.

Authors:  Daniel M Pinkas; Pavel Strop; Axel T Brunger; Chaitan Khosla
Journal:  PLoS Biol       Date:  2007-12       Impact factor: 8.029

View more
  2 in total

1.  Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.

Authors:  Na Tian; Guoxian Wei; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

Review 2.  Biosensors for the Diagnosis of Celiac Disease: Current Status and Future Perspectives.

Authors:  Katharina Anne Scherf; Rachele Ciccocioppo; Miroslav Pohanka; Kvetoslava Rimarova; Radka Opatrilova; Luis Rodrigo; Peter Kruzliak
Journal:  Mol Biotechnol       Date:  2016-06       Impact factor: 2.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.